3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Vascular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Prostatic Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioma
1
Fibrosarcoma
1
Esophageal Neoplasms
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Astrocytoma
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cisplatin
6
pembrolizumab
4
durvalumab
4
Platinum
4
Carboplatin
4
1,2-diaminocyclohexaneplatinum II citrate
4
cemiplimab
3
Radiation
3
Paclitaxel
3
Cetuximab
3
Biopsy
3
(225)Ac-DOTA-c(RGDyK)
3
cabozantinib
2
atezolizumab
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Pemetrexed
2
Nivolumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
ALT-803
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
repotrectinib
1
poly ICLC
1
ipatasertib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
Proton Therapy
×
30 days
×
Clear all
No trials found.